Literature DB >> 28684457

Pericortical Enhancement on Delayed Postgadolinium Fluid-Attenuated Inversion Recovery Images in Normal Aging, Mild Cognitive Impairment, and Alzheimer Disease.

W M Freeze1,2, R S Schnerr2, W M Palm2, J F Jansen2, H I Jacobs3, E I Hoff4, F R Verhey3, W H Backes2.   

Abstract

BACKGROUND AND
PURPOSE: Breakdown of BBB integrity occurs in dementia and may lead to neurodegeneration and cognitive decline. We assessed whether extravasation of gadolinium chelate could be visualized on delayed postcontrast FLAIR images in older individuals with and without cognitive impairment.
MATERIALS AND METHODS: Seventy-four individuals participated in this study (15 with Alzheimer disease, 33 with mild cognitive impairment, and 26 with normal cognition). We assessed the appearance of pericortical enhancement after contrast administration, MR imaging markers of cerebrovascular damage, and medial temporal lobe atrophy. Three participants who were positive for pericortical enhancement (1 with normal cognition and 2 with mild cognitive impairment) were followed up for approximately 2 years. In vitro experiments with a range of gadolinium concentrations served to elucidate the mechanisms underlying the postcontrast FLAIR signals.
RESULTS: Postcontrast pericortical enhancement was observed in 21 participants (28%), including 6 individuals with Alzheimer disease (40%), 10 with mild cognitive impairment (30%), and 5 with normal cognition (19%). Pericortical enhancement was positively associated with age (P < .02) and ischemic stroke (P < .05), but not with cognitive status (P = .3). Foci with enhanced signal remained stable across time in all follow-up cases. The in vitro measurements confirmed that FLAIR imaging is highly sensitive for the detection of low gadolinium concentrations in CSF, but not in cerebral tissue.
CONCLUSIONS: Postcontrast pericortical enhancement on FLAIR images occurs in older individuals with normal cognition, mild cognitive impairment, and dementia. It may represent chronic focal superficial BBB leakage. Future longitudinal studies are needed to determine its clinical significance.
© 2017 by American Journal of Neuroradiology.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28684457     DOI: 10.3174/ajnr.A5273

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  8 in total

1.  Circumventricular organs of human brain visualized on post-contrast 3D fluid-attenuated inversion recovery imaging.

Authors:  Minako Azuma; Toshinori Hirai; Yoshihito Kadota; Zaw Aung Khant; Yohei Hattori; Mika Kitajima; Hiroyuki Uetani; Yasuyuki Yamashita
Journal:  Neuroradiology       Date:  2018-05-02       Impact factor: 2.804

2.  Optimal Detection of Subtle Gadolinium Leakage in CSF with Heavily T2-Weighted Fluid-Attenuated Inversion Recovery Imaging.

Authors:  W M Freeze; D N Ter Weele; W M Palm; R W van Hooren; E I Hoff; J F A Jansen; H I L Jacobs; F R Verhey; W H Backes
Journal:  AJNR Am J Neuroradiol       Date:  2019-08-08       Impact factor: 3.825

Review 3.  Quantifying blood-brain barrier leakage in small vessel disease: Review and consensus recommendations.

Authors:  Michael J Thrippleton; Walter H Backes; Steven Sourbron; Michael Ingrisch; Matthias J P van Osch; Martin Dichgans; Franz Fazekas; Stefan Ropele; Richard Frayne; Robert J van Oostenbrugge; Eric E Smith; Joanna M Wardlaw
Journal:  Alzheimers Dement       Date:  2019-04-25       Impact factor: 21.566

4.  Contrast leakage distant from the hematoma in patients with spontaneous ICH: A 7 T MRI study.

Authors:  Wilmar Mt Jolink; Arjen Lindenholz; Ellis S van Etten; Koen M van Nieuwenhuizen; Floris Hbm Schreuder; Hugo J Kuijf; Matthias Jp van Osch; Jeroen Hendrikse; Gabriel Je Rinkel; Marieke Jh Wermer; Catharina Jm Klijn
Journal:  J Cereb Blood Flow Metab       Date:  2019-05-29       Impact factor: 6.200

5.  Detection of IV-gadolinium Leakage from the Cortical Veins into the CSF Using MR Fingerprinting.

Authors:  Shinji Naganawa; Toshiki Nakane; Hisashi Kawai; Toshiaki Taoka; Hirokazu Kawaguchi; Katsuya Maruyama; Katsutoshi Murata; Gregor Körzdörfer; Josef Pfeuffer; Mathias Nittka; Michihiko Sone
Journal:  Magn Reson Med Sci       Date:  2019-06-20       Impact factor: 2.471

Review 6.  Harmonizing brain magnetic resonance imaging methods for vascular contributions to neurodegeneration.

Authors:  Eric E Smith; Geert Jan Biessels; François De Guio; Frank Erik de Leeuw; Simon Duchesne; Marco Düring; Richard Frayne; M Arfan Ikram; Eric Jouvent; Bradley J MacIntosh; Michael J Thrippleton; Meike W Vernooij; Hieab Adams; Walter H Backes; Lucia Ballerini; Sandra E Black; Christopher Chen; Rod Corriveau; Charles DeCarli; Steven M Greenberg; M Edip Gurol; Michael Ingrisch; Dominic Job; Bonnie Y K Lam; Lenore J Launer; Jennifer Linn; Cheryl R McCreary; Vincent C T Mok; Leonardo Pantoni; G Bruce Pike; Joel Ramirez; Yael D Reijmer; Jose Rafael Romero; Stefan Ropele; Natalia S Rost; Perminder S Sachdev; Christopher J M Scott; Sudha Seshadri; Mukul Sharma; Steven Sourbron; Rebecca M E Steketee; Richard H Swartz; Robert van Oostenbrugge; Matthias van Osch; Sanneke van Rooden; Anand Viswanathan; David Werring; Martin Dichgans; Joanna M Wardlaw
Journal:  Alzheimers Dement (Amst)       Date:  2019-02-26

Review 7.  CSF enhancement on post-contrast fluid-attenuated inversion recovery images; a systematic review.

Authors:  Whitney M Freeze; Merel van der Thiel; Jeroen de Bresser; Catharina J M Klijn; Ellis S van Etten; Jacobus F A Jansen; Louise van der Weerd; Heidi I L Jacobs; Walter H Backes; Susanne J van Veluw
Journal:  Neuroimage Clin       Date:  2020-10-02       Impact factor: 4.881

8.  Intracranial Distribution of Intravenously Administered Gadolinium-based Contrast Agent over a Period of 24 Hours: Evaluation with 3D-real IR Imaging and MR Fingerprinting.

Authors:  Shinji Naganawa; Rintaro Ito; Yutaka Kato; Hisashi Kawai; Toshiaki Taoka; Tadao Yoshida; Katsuya Maruyama; Katsutoshi Murata; Gregor Körzdörfer; Josef Pfeuffer; Mathias Nittka; Michihiko Sone
Journal:  Magn Reson Med Sci       Date:  2020-04-15       Impact factor: 2.471

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.